US Stock MarketDetailed Quotes

MGNX Macrogenics

Watchlist
  • 3.640
  • +0.240+7.06%
Close Nov 27 16:00 ET
228.46MMarket Cap-2318P/E (TTM)

About Macrogenics Company

MacroGenics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of antibody-based therapeutics for the treatment of cancer. Its product pipeline includes Margetuximab, Flotetuzumab, Retifanlimab, Enoblituzumab, Tebotelimab, MGC018, MGD019, IMGC936, and MGD014 for infectious diseases. The company was founded by Scott E. Koenig, Jeffrey V. Ravetch, LeRoy E. Hood, Ruedi Aebersold, and Alan Aderem on August 14, 2000 and is headquartered in Rockville, MD.

Company Profile

SymbolMGNX
Company NameMacrogenics
Listing DateOct 10, 2013
Issue Price16.00
Founded2000
CEODr. Scott Koenig, M.D.,PhD
MarketNASDAQ
Employees339
Fiscal Year Ends12-31
Address9704 Medical Center Drive
CityRockville
ProvinceMaryland
CountryUnited States of America
Zip Code20850-3368
Phone1-301-251-5172
Websitehttp://www.macrogenics.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Scott Koenig, M.D.,PhD
  • Director, President and Chief Executive Officer
  • 3.71M
  • Eric Risser
  • Chief Operating Officer
  • --
  • James Karrels
  • Senior Vice President, Chief Financial Officer and Corporate Secretary
  • 1.58M
  • Dr. Stephen L. Eck
  • Senior Vice President, Clinical Development and Chief Medical Officer
  • 1.75M
  • Dr. Ezio Bonvini, M.D.
  • Senior Vice President, Research and Chief Scientific Officer
  • --
  • Jeffrey Stuart Peters
  • Senior Vice President, General Counsel and Corporate Compliance Officer
  • --
  • Thomas Spitznagel
  • Senior Vice President, Technical Operations
  • --
  • Lynn Cilinski
  • Vice President, Controller and Treasurer
  • --
  • William K. Heiden
  • Chairman of the Board
  • 180.13K
  • Dr. Margaret A. Liu, M.D.
  • Independent Director
  • 318.32K
  • Dr. David C. Stump,M.D.
  • Independent Director
  • 160.75K
  • Federica O'Brien
  • Independent Director
  • 152.00K
  • Dr. Karen Jean Ferrante, M.D.
  • Independent Director
  • 135.75K
  • Dr. Jay Siegel, M.D.
  • Independent Director
  • 167.21K
  • Meenu Chhabra Karson
  • Independent Director
  • 335.41K
  • Scott T. Jackson, M.B.A.
  • Independent Director
  • 167.63K
  • Edward M. Hurwitz, J.D.
  • Independent Director
  • 147.63K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data